Position in IXHL
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$15
New position
Shares Held
5
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#19
of 20 holders
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026DANSKE BANK A/S holds $84,030,013 across 13 Drug Manufacturers - Specialty & Generic names. IXHL ranks #11 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
299,003 | $35,345,143 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
604,233 | $14,459,295 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
17,029 | $10,097,855 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
322,523 | $9,830,501 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
284,939 | $8,582,362 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
42,516 | $5,601,057 | |
| 7 | VTRS |
Viatris Inc
|
8,000 | $108,080 | |
| 8 | ALKS |
Alkermes plc.
|
100 | $3,536 |
All Filings in IXHL
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $15 | 5 | Shares | Sole | 2026-05-12 | |
| No filing history on record for this holder in this stock. | ||||||